Abstract:Objective To explore the expression and clinical significance of chemokine receptor 6 (CCR6)/chemokine ligand 20(CCL20) axis in hepatocellular carcinoma (HCC).Methods From March 2003 to December 2005,48 patients with HCC were selected,and one specimen of HCC tissue and one of corresponding adjacent tissue were taken from every patient.Another eight patients with benign liver lesions were selected,and one specimen of surgical sectioned normal liver tissue of each was taken.The relative expression quantity of CCR6 and CCL20 at mRNA level was detected by real-time fluorescence quantitative polymerase chain reaction (qRT-PCR).And the expression of CCR6 and CCL20 at protein level was determined by immunohistochemisty methods.One-way analysis of variance (ANOVA) was performed for comparison among groups of measurement data.Chi-square test was used for rate comparison.The correlation coefficient was calculated by Spearman's method.Survival curves were plotted by Kaplan-Meier method and the survival rate was compared by Log-rank test.Results The relative expression quantity of CCR6/CCL20 at mRNA level in HCC tissues (0.99±0.21 and 0.46± 0.11) were significantly higher than those of para carcinoma tissues (0.33 ± 0.09 and 0.31 ± 0.07) and normal liver tissues (0.22±0.06 and 0.28±0.05),and the differences were statistically significant (F=127.43 and 21.10,both P＜0.05).The positive percentage of CCR6 protein expression in HCC tissues (54.17％,26/48) was significantly higher than that in para carcinoma tissues (16.67％,8/48) and normal liver tissues (0/8),and the difference was statistically significant (x2 =19.55,P＜0.05).There was no statistically significant difference in the positive percentage of CCL20 protein expression among HCC tissues (50.00％,24/48),paracarcinoma tissues (33.33％,16/48),normal liver tissues (2/8) (all P＜0.05).There was correlation between the positive percentage of CCR6 protein expression and that of CCL20 protein expression in HCC tissues (r=0.42,P＜0.05).The positive percentage of CCR6 protein expression was correlated with the pTNM stage of HCC,vascular tumor thrombosis,intrahepatic metastasis and lung metastasis (x2 =5.48,4.02,5.07 and 5.19,all P＜0.05).The positive percentage of CCL20 expression was significantly correlated to tumor maximum diameter and pTNM stage (x2 =4.09 and 4.00,both P＜0.05).Both the disease-free survival (DFS) rate and overall survival (OS) rate of CCR6-positive group were significantly lower than those of negative group (x2 =4.57 and 6.57,both P＜ 0.05).There were no significant differences in DFS rate and OS rate between CCL20-positive group and negative group (both P＞0.05).Conclusion CCR6/CCL20 axis may be related with the malignant behavior and the prognosis of HCC.

Expression and Significants of Transcription Factor KLF6 and Sp1 Protein in Human Hepatocellular Carcinoma and Hepatic Cirrhosis Tissues

Expression of KLF6 protein in tissue of hepatocellular carcinoma and its significance

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

Correlation of transcription factor Sp1 expression with clinical and pathological characteristics and prognosis of hepatocellular carcinoma

Expression of KLF8 in Hepatocellular Carcinoma and Its Significance

Expression and Clinical Significance of Heat Shock Transcription Factor 1 Protein in Human Hepatocellular Carcinoma Tissues

Expression of Tumor Suppressor Kruppel-like Factor 6 (KLF6) Gene in Hepatocellular Carcinoma and Its Effect on Growth of SMMC-7721 Cells

FOXP1 and SPINK1 Reflect the Risk of Cirrhosis Progression to HCC with HBV Infection.

Significance of Expression of Thrombospondin- 1 and Receptor- CD36 in Hepatocellular Carcinoma

Effect of KLF6 and Its Splice Variant KLF6V on Proliferation and Differentiation of Human Hepatocellular Carcinoma HepG2 Cells

Inactivation of the Tumor Suppressor Krüppel-like Factor 6 (KLF6) by Mutation or Decreased Expression in Hepatocellular Carcinomas

The expression of C-fos and EGFR in human hepatocellular carcinoma and hepatic cirrhosis tissues.

Expressions of Survivin,caspase-3 and NF-κB in Hepatocellular Carcinoma and Their Correlation

The Expression and Significance of Tumor Necrosis Factor Receptor 1 in Human Hepatocellular Carcinoma

Expression of TSLC1 protein in human hepatocellular carcinoma and its clinical significance

Expression and its clinical significance of chemokine receptor 6/chemokine ligand 20 axis in hepatocellular carcinoma

Initial Study on the Expression of SPP-1,GDF-15 and CXCL-1 in Human Small Hepatocellular Carcinoma

Clinical Significance and Biological Function of Co-Stimulation Molecule B7 Homolog 6 Expression in Human Hepatocellular Carcinoma

Interaction of KLF6 and Sp1 regulates basigin-2 expression mediated proliferation, invasion and metastasis in hepatocellular carcinoma

Comprehensive Analysis of KLF2 As a Prognostic Biomarker Associated with Fibrosis and Immune Infiltration in Advanced Hepatocellular Carcinoma.

Important Oncogenic and Immunogenic Roles of SPP1 and CSF1 in Hepatocellular Carcinoma